PFBT
XENE icon

Parkside Financial Bank & Trust’s Xenon Pharmaceuticals XENE Stock Holding History

Parkside Financial Bank & Trust’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75K Hold
30
– – ﹤0.01% 2165
2025
Q4 		$1.34K Hold
30
– – ﹤0.01% 2238
2025
Q3 		$1.21K Hold
30
– – ﹤0.01% 2212
2025
Q2 		$939 Buy
+30
New +$979 ﹤0.01% 2287

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parkside Financial Bank & Trust's XENE Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Xenon Pharmaceuticals (XENE) position steady in Q1 2026 at 30 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Parkside Financial Bank & Trust first reported a position in XENE in Q2 2025 and has held it in 4 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • Parkside Financial Bank & Trust held 30 shares of Xenon Pharmaceuticals worth $1.75K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Xenon Pharmaceuticals share count unchanged in Q1 2026.
  • Xenon Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2165 holding.
  • Parkside Financial Bank & Trust first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.